SEARCH

SEARCH BY CITATION

Advances in mechanical circulatory devices have challenged heart transplantation as the gold standard therapy for patients with heart failure. This month, we explore just how close we are to tipping the balance between using the devices as bridges to transplantation and as destination therapies. Also this month, we look at possible changes to the OPTN/UNOS heart allocation policy.